Biopure Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. Hemopure® [hemoglobin glutamer - 250 (bovine)], or HBOC-201, is approved for sale in South Africa for the treatment of surgical patients who are acutely anemic. Biopure has applied in the United Kingdom for regulatory approval of a proposed orthopedic surgical anemia indication. The company is developing Hemopure for other indications and is supporting the U.S. Navy's government-funded efforts to develop a potential out-of-hospital trauma indication. Biopure's veterinary product Oxyglobin® [hemoglobin glutamer - 200 bovine)], or HBOC-301, the only oxygen therapeutic approved for marketing by both the U.S. Food and Drug Administration and the European Commission, is indicated for the treatment of anemia in dogs. Biopure has sold approximately 190,000 units of Oxyglobin.
View Top Employees from Biopure CorporationWebsite | http://www.biopure.com |
Revenue | $12 million |
Employees | View employees |
Address | 11 Hurley St, Cambridge, Massachusetts 02141, US |
Phone | (617) 234-6500 |
Fax | (617) 234-6505 |
Industry | Manufacturing General, Manufacturing |
Competitors | Camellix, LLC, Constellation Pharmaceuticals, A MorphoSys Company, NuvOx Pharma, QPharma AB, Welichem Biotech Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 325414 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Biopure Corporation employee's phone or email?
The Biopure Corporation annual revenue was $12 million in 2024.
Biopure Corporation is based in Cambridge, Massachusetts.
The NAICS codes for Biopure Corporation are [325, 32, 325414, 32541, 3254].
The SIC codes for Biopure Corporation are [283, 28].